# Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms

> **NCT01300819** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 349 (actual)

## Conditions studied

- Idiopathic Parkinson's Disease

## Interventions

- **OTHER:** Placebo
- **DRUG:** Rotigotine

## Key facts

- **NCT ID:** NCT01300819
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-10
- **Final completion:** 2012-11
- **Target enrollment:** 349 (ACTUAL)
- **Last updated:** 2014-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01300819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01300819, "Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01300819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*